Human CD44v6 Antibody

Catalog # Availability Size / Price Qty
BBA13
Human CD44v6 Antibody in Data
2 Images
Product Details
Citations (20)
FAQs
Supplemental Products
Reviews (1)

Human CD44v6 Antibody Summary

Species Reactivity
Human
Specificity
Detects human CD44v6 in Western blots. By flow cytometry analysis using a panel of CD44-transfected COS cells (9), monoclonal antibody clone 2F10 was deduced to be specific for human CD44 protein isoforms containing variant exon 6 (CD44v6).
Source
Monoclonal Mouse IgG1 Clone # 2F10
Purification
Protein A or G purified from ascites
Immunogen
Recombinant human CD44 v3-10
Formulation
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
Label
Unconjugated

Applications

Recommended Concentration
Sample
Western Blot
1 µg/mL
Recombinant Human CD44 Fc Chimera (Catalog # 3660-CD)
Flow Cytometry
0.25 µg/106 cells
See below
Immunohistochemistry
1-25 µg/mL
See below
Immunoprecipitation
Fox, S.B. et al. (1994) Cancer Res. 54:4539.
 
CyTOF-ready
Ready to be labeled using established conjugation methods. No BSA or other carrier proteins that could interfere with conjugation.
 
Immunocytochemistry
8-25 µg/mL
Immersion fixed human peripheral blood mononuclear cells

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Data Examples

Flow Cytometry Detection of CD44 antibody in Human Blood Monocytes antibody by Flow Cytometry. View Larger

Detection of CD44 in Human Blood Monocytes by Flow Cytometry. Human peripheral blood monocytes were stained with Mouse Anti-Human CD44 v6 Monoclonal Antibody (Catalog # BBA13, filled histogram) or isotype control antibody (Catalog # MAB002, open histogram), followed by Allophycocyanin-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # F0101B).

Immunohistochemistry CD44 antibody in Human Colon Adenocarcinoma Tissue by Immunohistochemistry (IHC-P). View Larger

CD44 in Human Colon Adenocarcinoma Tissue. CD44 was detected in immersion fixed paraffin-embedded sections of human colon adenocarcinoma tissue using Mouse Anti-Human CD44 v6 Monoclonal Antibody (Catalog # BBA13) at 1.7 µg/mL for 1 hour at room temperature followed by incubation with the Anti-Mouse IgG VisUCyte™ HRP Polymer Antibody (Catalog # VC001). Before incubation with the primary antibody, tissue was subjected to heat-induced epitope retrieval using Antigen Retrieval Reagent-Basic (Catalog # CTS013). Tissue was stained using DAB (brown) and counterstained with hematoxylin (blue). Specific staining was localized to plasma membrane. View our protocol for IHC Staining with VisUCyte HRP Polymer Detection Reagents.

Reconstitution Calculator

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Preparation and Storage

Reconstitution
Sterile PBS to a final concentration of 0.5 mg/mL.
Reconstitution Buffer Available
Reconstitution Buffer 1 (PBS)
Catalog #
Availability
Size / Price
Qty
RB01
Shipping
The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 12 months from date of receipt, -20 to -70 °C as supplied.
  • 1 month, 2 to 8 °C under sterile conditions after reconstitution.
  • 6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: CD44

CD44 is a ubiquitously expressed protein that is the major receptor for hyaluronan and exerts control over cell growth and migration (1‑3). Human CD44 has a 20 amino acid (aa) signal sequence, an extracellular domain (ECD) with a 100 aa hyaluronan‑binding disulfide‑stabilized link region and a 325‑530 aa stem region, a 21 aa transmembrane domain, and a 72 aa cytoplasmic domain. Within the stem, ten variably spliced exons (v1‑10, exons 6‑15) produce multiple protein isoforms (1‑3). The standard or hematopoietic form, CD44H, does not include the variable segments (1‑3). Cancer aggressiveness and T cell activation have been correlated with expression of specific isoforms (1, 3). CD44v6 contains exon 10 and is associated with tumor progression and metastasis in many types of cancer including breast, colon, lung, renal, skin, and ovarian tumors. With variable N‑ and O‑glycosylation and splicing within the stalk, CD44 can range from 80 to 200 kDa (1). Within the N‑terminal invariant portion of the ECD (aa 21‑220), human CD44 shares 76%, 76%, 86%, 83% and 79% identity with corresponding mouse, rat, equine, canine and bovine CD44, respectively. The many reported functions of CD44 fall within three categories (1). First, CD44 binds hyaluronan and other ligands within the extracellular matrix and can function as a “platform” for growth factors and metalloproteinases. Second, CD44 can function as a co‑receptor that modifies activity of receptors including MET and the ERBB family of tyrosine kinases. Third, the CD44 intracellular domain links the plasma membrane to the actin cytoskeleton via the ERM proteins, ezrin, radixin and moesin. CD44 can be synthesized in a soluble form (4) or may be cleaved at multiple sites by either membrane‑type matrix metalloproteinases, or ADAM proteases to produce soluble ectodomains (5, 6). The cellular portion may then undergo gamma secretase‑dependent intramembrane cleavage to form an A beta ‑like transmembrane portion and a cytoplasmic signaling portion that affects gene expression (7, 8). These cleavage events are thought to promote metastasis by enhancing tumor cell motility and growth (1, 5).

References
  1. Ponta, H. et al. (2003) Nat. Rev. Mol. Cell Biol. 4:33.
  2. Screaton, G.R. et al. (1992) Proc. Natl. Acad. Sci. USA 89:12160.
  3. Lynch, K.W. (2004) Nat. Rev. Immunol. 4:931.
  4. Yu, Q. and B.P. Toole (1996) J. Biol. Chem. 271:20603.
  5. Nagano, O. and H. Saya (2004) Cancer Sci. 95:930.
  6. Nakamura, H. et al. (2004) Cancer Res. 64:876.
  7. Murakami, D. et al. (2003) Oncogene 22:1511.
  8. Lammich, S. et al. (2002) J. Biol. Chem. 277:44754.
  9. Fox, S.B. et al. (1994) Cancer Res. 54:4539.
Entrez Gene IDs
960 (Human); 12505 (Mouse); 25406 (Rat); 100126860 (Porcine)
Alternate Names
CD44 antigen; CD44 molecule (Indian blood group); CD44; CD44R; CDw44; cell surface glycoprotein CD44; chondroitin sulfate proteoglycan 8; CSPG8; ECMR-III; epican; Extracellular matrix receptor III; GP90 lymphocyte homing/adhesion receptor; HCAM; HCELL; hematopoietic cell E- and L-selectin ligand; Heparan sulfate proteoglycan; Hermes antigen; homing function and Indian blood group system; HUTCH-I; Hyaluronate receptor; IN; LHR; MC56; MDU2; MDU2CD44 antigen (homing function and Indian blood group system); MDU3; MDU3CDW44; MIC4; MIC4MGC10468; MUTCH-I; Pgp1; PGP-1; PGP-I; Phagocytic glycoprotein 1; Phagocytic glycoprotein I

Product Datasheets

Citations for Human CD44v6 Antibody

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.

20 Citations: Showing 1 - 10
Filter your results:

Filter by:

  1. CD44v6 Targeted by miR-193b-5p in the Coding Region Modulates the Migration and Invasion of Breast Cancer Cells
    Authors: S Hu, M Cao, Y He, G Zhang, Y Liu, Y Du, C Yang, F Gao
    J Cancer, 2020;11(1):260-271.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  2. Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant
    Authors: V Veschi, LR Mangiapane, A Nicotra, S Di Franco, E Scavo, T Apuzzo, DS Sardina, M Fiori, A Benfante, ML Colorito, G Cocorullo, F Giuliante, C Cipolla, G Pistone, MR Bongiorno, A Rizzo, CM Tate, X Wu, S Rowlinson, LF Stancato, M Todaro, R De Maria, G Stassi
    Oncogene, 2019;0(0):.
    Species: Human
    Sample Types: Whole Cells
    Applications: ICC
  3. Clinical impact of different exosomes' protein expression in pancreatic ductal carcinoma patients treated with standard first line palliative chemotherapy
    Authors: R Giampieri, F Piva, G Occhipinti, A Bittoni, A Righetti, S Pagliarett, A Murrone, F Bianchi, C Amantini, M Giulietti, G Ricci, G Principato, G Santoni, R Berardi, S Cascinu
    PLoS ONE, 2019;14(5):e0215990.
    Species: Human
    Sample Types: Plasma
    Applications: ELISA Detection
  4. CD44 targeted delivery of siRNA by using HA-decorated nanotechnologies for KRAS silencing in cancer treatment
    Authors: A Tirella, K Kloc-Munia, L Good, J Ridden, M Ashford, S Puri, N Tirelli
    Int J Pharm, 2019;0(0):.
  5. Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells
    Authors: T Navas, TD Pfister, S Colantonio, A Aziz, L Dieckman, RG Saul, J Kaczmarczy, S Borgel, SY Alcoser, MG Hollingshe, YH Lee, DP Bottaro, T Hiltke, G Whiteley, N Takebe, RJ Kinders, RE Parchment, JE Tomaszewsk, JH Doroshow
    PLoS ONE, 2018;13(6):e0199361.
    Species: Xenograft
    Sample Types: Whole Tissue
    Applications: IHC
  6. Musashi-1 promotes a cancer stem cell lineage and chemoresistance in colorectal cancer cells
    Authors: GY Chiou, TW Yang, CC Huang, CY Tang, JY Yen, MC Tsai, HY Chen, N Fadhilah, CC Lin, YJ Jong
    Sci Rep, 2017;7(1):2172.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  7. Autophagy supports generation of cells with high CD44 expression via modulation of oxidative stress and Parkin-mediated mitochondrial clearance
    Authors: KA Whelan, PM Chandramou, K Tanaka, M Natsuizaka, M Guha, S Srinivasan, DS Darling, Y Kita, S Natsugoe, JD Winkler, AJ Klein-Szan, RK Amaravadi, NG Avadhani, AK Rustgi, H Nakagawa
    Oncogene, 2017;0(0):.
    Species: Human
    Sample Types: Cell Lysates
    Applications: Western Blot
  8. Isolation of All CD44 Transcripts in Human Epidermis and Regulation of Their Expression by Various Agents
    PLoS ONE, 2016;11(8):e0160952.
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC-P
  9. Nomogram Incorporating CD44v6 and Clinicopathological Factors to Predict Lymph Node Metastasis for Early Gastric Cancer
    PLoS ONE, 2016;11(8):e0159424.
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC-P
  10. MIF allele-dependent regulation of the MIF coreceptor CD44 and role in rheumatoid arthritis
    Proc. Natl. Acad. Sci. U.S.A., 2016;113(49):E7917-E7926.
    Species: Mouse
    Sample Types: Whole Cells
    Applications: Flow Cytometry
  11. CD44 mediates the Catch-Bond Activated Rolling of HEPG2 Epithelial Cancer Cells on Hyaluronan
    Authors: Axel Rosenhahn
    Cell Adh Migr, 2016;0(0):0.
    Species: Human
    Sample Types: Whole Cells
    Applications: Bioassay
  12. Dynamic regulation of the cancer stem cell compartment by Cripto-1 in colorectal cancer.
    Authors: Francescangeli F, Contavalli P, De Angelis M, Baiocchi M, Gambara G, Pagliuca A, Fiorenzano A, Prezioso C, Boe A, Todaro M, Stassi G, Castro N, Watanabe K, Salomon D, De Maria R, Minchiotti G, Zeuner A
    Cell Death Differ, 2015;22(10):1700-13.
    Species: Human
    Sample Types: Whole Cells
    Applications: Flow Cytometry
  13. Evaluation of protein biomarkers of prostate cancer aggressiveness.
    Authors: Rizzardi A, Rosener N, Koopmeiners J, Isaksson Vogel R, Metzger G, Forster C, Marston L, Tiffany J, McCarthy J, Turley E, Warlick C, Henriksen J, Schmechel S
    BMC Cancer, 2014;14(0):244.
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC-P
  14. Overexpression of progelatinase B/proMMP-9 affects migration regulatory pathways and impairs chronic lymphocytic leukemia cell homing to bone marrow and spleen.
    Authors: Bailon E, Ugarte-Berzal E, Amigo-Jimenez I, Van den Steen P, Opdenakker G, Garcia-Marco J, Garcia-Pardo A
    J Leukoc Biol, 2014;96(2):185-99.
    Species: Human
    Sample Types: Whole Cells
    Applications: Flow Cytometry
  15. CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis.
    Authors: Todaro M, Gaggianesi M, Catalano V, Benfante A, Iovino F, Biffoni M, Apuzzo T, Sperduti I, Volpe S, Cocorullo G, Gulotta G, Dieli F, De Maria R, Stassi G
    Cell Stem Cell, 2014;14(3):342-56.
    Species: Human
    Sample Types: Whole Cells
    Applications: Neutralization
  16. Establishment of highly tumorigenic human colorectal cancer cell line (CR4) with properties of putative cancer stem cells.
    Authors: Rowehl, Rebecca, Burke, Stephani, Bialkowska, Agnieszk, Pettet, Donald W, Rowehl, Leahana, Li, Ellen, Antoniou, Eric, Zhang, Yuanhao, Bergamaschi, Roberto, Shroyer, Kenneth, Ojima, Iwao, Botchkina, Galina I
    PLoS ONE, 2014;9(6):e99091.
    Species: Human
    Sample Types: Whole Cells
    Applications: Flow Cytometry
  17. Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay.
    Authors: Baccelli I, Schneeweiss A, Riethdorf S, Stenzinger A, Schillert A, Vogel V, Klein C, Saini M, Bauerle T, Wallwiener M, Holland-Letz T, Hofner T, Sprick M, Scharpff M, Marme F, Sinn H, Pantel K, Weichert W, Trumpp A
    Nat Biotechnol, 2013;31(6):539-44.
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC-P
  18. Expression of the CD44v2-10 isoform confers a metastatic phenotype: importance of the heparan sulfate attachment site CD44v3.
    Authors: Barbour AP, Reeder JA, Walsh MD, Fawcett J, Antalis TM, Gotley DC
    Cancer Res., 2003;63(4):887-92.
    Species: Human
    Sample Types: Whole Tissue
    Applications: IHC-P
  19. Effect of hyaluronan on xenotransplanted breast cancer.
    Authors: Herrera-Gayol A, Jothy S
    Exp. Mol. Pathol., 2002;72(3):179-85.
    Species: Human
    Sample Types: Whole Cells
    Applications: ICC
  20. CD44 is exposed to the extracellular matrix at invasive sites in basal cell carcinomas.
    Authors: Dingemans KP, Ramkema MD, Pals ST
    Lab. Invest., 2002;82(3):313-22.
    Species: Human
    Sample Types: Whole Cells
    Applications: Electron Microscopy

FAQs

No product specific FAQs exist for this product, however you may

View all Antibody FAQs

Cell and Tissue Staining Kits

Immunohistochemistry Reagents

Isotype Controls

Reconstitution Buffers

Secondary Antibodies

Reviews for Human CD44v6 Antibody

Average Rating: 5 (Based on 1 Review)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Have you used Human CD44v6 Antibody?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review

Filter by:


Human CD44v6 Antibody
By Anonymous on 11/08/2018
Application: ELISA Sample Tested: EDTA Plasma Species: Human